P575 Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
Author(s) -
Luisa Guidi,
Daniela Pugliese,
Tommaso Panici Tonucci,
Barbara Tolusso,
Carla Felice,
Clara Di Mario,
Alfredo Papa,
Elisa Gremese,
Antonio Gasbarrini,
G.L. Rapaccini,
Alessandro Armuzzi
Publication year - 2018
Publication title -
journal of crohn s and colitis
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1093/ecco-jcc/jjx180.702
Subject(s) - vedolizumab , medicine , ulcerative colitis , gastroenterology , inflammatory bowel disease , concomitant , receiver operating characteristic , area under the curve , mann–whitney u test , trough level , crohn's disease , disease , transplantation , tacrolimus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom